Data / Form D filings / ABBOTT LABORATORIES
ABBOTT LABORATORIES: Form D filings
ABBOTT LABORATORIES, a pharmaceuticals company in Abbott Park, IL, filed 3 Form D notices with the SEC between 2009 and 2011. The latest, on March 15, 2011, reports $100,000 sold of a $100,000 offering to 1 investor.
Find out what ABBOTT LABORATORIES does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 100 Abbott Park Road, Abbott Park, IL, 60064
- Phone
- (847) 937-6100
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Illinois
- Revenue range
- Over $100,000,000
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1800
The full lists. Form D filings in Illinois: 1,511 rows, $75.55, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 15, 2011 | New notice | $100,000 | $100,000 | $0 | 1 | Mar 1, 2011 | sec.gov |
| Mar 12, 2010 | New notice | $70,000 | $70,000 | $0 | 1 | Mar 1, 2010 | sec.gov |
| Mar 13, 2009 | New notice | $6,690,000 | $6,690,000 | $0 | 6 | Mar 2, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Carlos J. Alban | Executive Officer | |
| William D. Smithburg | Director | |
| Glenn F. Tilton | Director | |
| Edward L. Michael | Executive Officer | |
| Roxanne S. Austin | Director | |
| Greg W. Linder | Executive Officer | |
| Edward M. Liddy | Director | |
| James V. Mazzo | Executive Officer | |
| John M. Capek | Executive Officer | |
| John C. Landgraf | Executive Officer | |
| Mary T. Szela | Executive Officer | |
| Miles D. White | Executive Officer, Director | |
| Heather L. Mason | Executive Officer | |
| William A. Osborn | Director | |
| Richard A. Gonzalez | Executive Officer | |
| Laura J. Schumacher | Executive Officer | |
| Brian J. Blaser | Executive Officer | |
| J. Scott White | Executive Officer | |
| Robert J. Alpern | Director | |
| Richard W. Ashley | Executive Officer | |
| Stephen R. Fussell | Executive Officer | |
| Thomas C. Freyman | Executive Officer | |
| Phebe N. Novakovic | Director | |
| Samuel C. Scott III | Director | |
| A. David Forrest | Executive Officer | |
| Robert B. Hance | Executive Officer | |
| Roy S. Roberts | Director | |
| David A.L. Owen | Director | |
| H. Laurance Fuller | Director | |
| Michael J. Warmuth | Executive Officer | |
| W. James Farrell | Director |
Every Form D from the week of Mar 14, 2011 · All recent filings in Illinois · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what ABBOTT LABORATORIES reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.